Featured Posts
National Review
Prescription Drugs Save Lives at a (Mostly) Reasonable Cost
Prescription drugs are an extraordinary lifesaving and life-enhancing technology, so integrated into our daily lives that, nowadays, we perhaps take them for granted. Headlines and…
Blog
What Trump’s vaccine executive order actually does
Yesterday, President Trump signed an executive order directing federal health agencies to revise childhood vaccine recommendations, reducing the number of vaccines recommended for…
Blog
Trump administration decision highlights disastrous Part D redesign
The Trump administration recently announced the end of a demonstration project that was pulled together by the Biden administration as the Inflation Reduction…
Search Posts
MPR News
Little Change to Agriculture Policy, Even as Peterson Loses Chair
MPR News
Angela Logomasini On The Risk of BPA
CEI Director of Risk and Environmental Policy Angela Logomasini discusses the risks and…
MPR News
High Cost Is Not Worst Thing About Obamacare (Letter to the Editor)
The Examiner was right to criticize Obamacare for being even more costly than many of its opponents expected, but the worst things about it…
MPR News
Upstream Battle for Genetically Engineered Salmon
Over the last two decades, the use of modern genetic engineering technology to produce pharmaceuticals and new crop plants has given rise to prodigious scientific,…
MPR News
Don’t Blame BPA on Lobster Decline
If you trust the headlines, you might think that the biggest challenge facing the lobster industry in New York and New England is pollution —…
Comment
CEI Comments regarding FDA’s Draft Guidance on the Judicious Use of Medically Important Antimicrobial Drugs in Food-Producing Animals
Executive Summary The Competitive Enterprise Institute respectfully submits these comments on the agency’s Draft Guidance on The Judicious Use of Medically Important Antimicrobial…